软骨
内科学
滑膜炎
骨关节炎
前列腺素E2
II型胶原
医学
内分泌学
发病机制
基质金属蛋白酶
化学
蛋白多糖
分子生物学
炎症
前列腺素
关节炎
病理
生物
解剖
替代医学
作者
Mehdi Najar,Yassine Ouhaddi,Frédéric Paré,Bertrand Lussier,Yoshihiro Urade,Mohit Kapoor,Jean‐Pierre Pelletier,Johanne Martel‐Pelletier,Mohamed Benderdour,Hassan Fahmi
摘要
OBJECTIVE: ), which has important roles in inflammation and cartilage metabolism. We undertook this study to investigate the role of L-PGDS in the pathogenesis of osteoarthritis (OA) using an experimental mouse model. METHODS: and WT mice (n = 6 per genotype) were treated with interleukin-1α (IL-1α) ex vivo in order to evaluate proteoglycan degradation. Moreover, the effect of intraarticular injection of a recombinant adeno-associated virus type 2/5 (rAAV2/5) encoding L-PGDS on OA progression was evaluated in WT mice (n = 9 per group). RESULTS: mice showed enhanced proteoglycan degradation following treatment with IL-1α (P < 0.05). Intraarticular injection of rAAV2/5 encoding L-PGDS attenuated the severity of DMM-induced OA-like changes in WT mice (P < 0.05). The L-PGDS level was increased in OA tissues of WT mice (P < 0.05). CONCLUSION: Collectively, these findings suggest a protective role of L-PGDS in OA, and therefore enhancing levels of L-PGDS may constitute a promising therapeutic strategy.
科研通智能强力驱动
Strongly Powered by AbleSci AI